FDA Inspection 1258203 — Daewoo Pharmaceutical Co., Ltd.
The FDA completed an inspection of Daewoo Pharmaceutical Co., Ltd. on Jan 15, 2025 in Saha. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Jan 15, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Saha (Korea (the Republic of))